Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Mast cells as regulators of adaptive immunity to tumours.

Literature DB >> 19077084

Mast cells as regulators of adaptive immunity to tumours.

A Wasiuk¹, V C de Vries, K Hartmann, A Roers, R J Noelle.

Abstract

The observation that mast cells accumulate at the periphery of growing tumours is now well documented, and the loss of mast cells correlates with reduced tumour growth. The role of mast cells as innate regulators of both inflammatory and immunosuppressive responses slowly becomes clear as novel tools become available. This review will address the role of mast cells in tumours and how they can interact with the local immune environment to mediate immune suppression contributing to tumour escape.

Entities: Disease

Mesh：

Year: 2008 PMID： 19077084 PMCID： PMC2675243 DOI： 10.1111/j.1365-2249.2008.03840.x

Source DB: PubMed Journal: Clin Exp Immunol ISSN： 0009-9104 Impact factor: 4.330

68 in total

1. Tumor-infiltrating dendritic cells are defective in their antigen-presenting function and inducible B7 expression in rats.

Authors: P Chaux; N Favre; M Martin; F Martin
Journal: Int J Cancer Date: 1997-08-07 Impact factor: 7.396

2. The potential role of mast cells in lung allograft rejection.

Authors: S A Yousem
Journal: Hum Pathol Date: 1997-02 Impact factor: 3.466

3. Immune surveillance against a solid tumor fails because of immunological ignorance.

Authors: A F Ochsenbein; P Klenerman; U Karrer; B Ludewig; M Pericin; H Hengartner; R M Zinkernagel
Journal: Proc Natl Acad Sci U S A Date: 1999-03-02 Impact factor: 11.205

4. Ultraviolet B irradiation of skin induces mast cell degranulation and release of tumour necrosis factor-alpha.

Authors: L J Walsh
Journal: Immunol Cell Biol Date: 1995-06 Impact factor: 5.126

5. Inhibitors of serotonin synthesis and antagonists of serotonin 1A receptors inhibit T lymphocyte function in vitro and cell-mediated immunity in vivo.

Authors: T M Aune; H W Golden; K M McGrath
Journal: J Immunol Date: 1994-07-15 Impact factor: 5.422

6. Secretion of IL-16 (lymphocyte chemoattractant factor) from serotonin-stimulated CD8+ T cells in vitro.

Authors: S Laberge; W W Cruikshank; D J Beer; D M Center
Journal: J Immunol Date: 1996-01-01 Impact factor: 5.422

7. Mast-cell-deficient W/Wv mice exhibit a decreased rate of tumor angiogenesis.

Authors: J R Starkey; P K Crowle; S Taubenberger
Journal: Int J Cancer Date: 1988-07-15 Impact factor: 7.396

8. IL-6 production by rat peritoneal mast cells is not necessarily preceded by histamine release and can be induced by bacterial lipopolysaccharide.

Authors: I Leal-Berumen; P Conlon; J S Marshall
Journal: J Immunol Date: 1994-06-01 Impact factor: 5.422

9. Mast cells in colorectal neoplasias and premalignant disorders.

Authors: J Lachter; M Stein; C Lichtig; S Eidelman; M Munichor
Journal: Dis Colon Rectum Date: 1995-03 Impact factor: 4.585

10. Dermal mast cells determine susceptibility to ultraviolet B-induced systemic suppression of contact hypersensitivity responses in mice.

Authors: P H Hart; M A Grimbaldeston; G J Swift; A Jaksic; F P Noonan; J J Finlay-Jones
Journal: J Exp Med Date: 1998-06-15 Impact factor: 14.307

35 in total

Review 1. Phenotypic and functional plasticity of cells of innate immunity: macrophages, mast cells and neutrophils.

Authors: Stephen J Galli; Niels Borregaard; Thomas A Wynn
Journal: Nat Immunol Date: 2011-10-19 Impact factor: 25.606

2. A transcriptomic insight into the impacts of mast cells in lung, breast, and colon cancers.

Authors: Eun-A Ko; Kenton M Sanders; Tong Zhou
Journal: Oncoimmunology Date: 2017-08-08 Impact factor: 8.110

3. Kit (W-sh) mice develop earlier and more severe experimental autoimmune encephalomyelitis due to absence of immune suppression.

Authors: Hongmei Li; Bardia Nourbakhsh; Farinaz Safavi; Ke Li; Hui Xu; Melissa Cullimore; Fang Zhou; Guangxian Zhang; Abdolmohamad Rostami
Journal: J Immunol Date: 2011-06-06 Impact factor: 5.422

4. Mast cells are novel independent prognostic markers in prostate cancer and represent a target for therapy.

Authors: Anna Johansson; Stina Rudolfsson; Peter Hammarsten; Sofia Halin; Kristian Pietras; Jonathan Jones; Pär Stattin; Lars Egevad; Torvald Granfors; Pernilla Wikström; Anders Bergh
Journal: Am J Pathol Date: 2010-07-08 Impact factor: 4.307

5. Lansiumamide B and SB-204900 isolated from Clausena lansium inhibit histamine and TNF-α release from RBL-2H3 cells.

Authors: Takuya Matsui; Chihiro Ito; Hiroshi Furukawa; Tadashi Okada; Masataka Itoigawa
Journal: Inflamm Res Date: 2013-01-17 Impact factor: 4.575

Review 6. Mast cell and T cell communication; amplification and control of adaptive immunity.

Authors: Alon Y Hershko; Juan Rivera
Journal: Immunol Lett Date: 2009-11-10 Impact factor: 3.685

7. Effects of myenteric denervation on extracellular matrix fibers and mast cell distribution in normal stomach and gastric lesions.

Authors: Cássia F Estofolete; Carla Botelho-Machado; Sebastião R Taboga; Sérgio Zucoloto; Ana Cláudia Polli-Lopes; Cristiane D Gil
Journal: Cancer Cell Int Date: 2010-06-22 Impact factor: 5.722

8. High-avidity T cells are preferentially tolerized in the tumor microenvironment.

Authors: Ziqiang Zhu; Vinod Singh; Stephanie K Watkins; Vincenzo Bronte; Jennifer L Shoe; Lionel Feigenbaum; Arthur A Hurwitz
Journal: Cancer Res Date: 2012-11-30 Impact factor: 12.701

9. Mast Cells in Adjacent Normal Colon Mucosa rather than Those in Invasive Margin are Related to Progression of Colon Cancer.

Authors: Qing Xia; Ya Ding; Xiao-Jun Wu; Rui-Qing Peng; Qiang Zhou; Jing Zeng; Jing-Hui Hou; Xing Zhang; Yi-Xin Zeng; Xiao-Shi Zhang; Ying-Bo Chen
Journal: Chin J Cancer Res Date: 2011-12 Impact factor: 5.087

Review 10. Challenges and opportunities in treating inflammation associated with pulmonary hypertension.

Authors: Norbert F Voelkel; Rasa Tamosiuniene; Mark R Nicolls
Journal: Expert Rev Cardiovasc Ther Date: 2016-05-04